They threw me off the hay truck at noon - PowerPoint PPT Presentation

1 / 32
About This Presentation
Title:

They threw me off the hay truck at noon

Description:

1999: pancreatic neuroendocrine (NE) tumor, whipple, Dx with von Hippel-Lindau ... I have heard the mermaids singing, each to each. TS Elliott ' ... – PowerPoint PPT presentation

Number of Views:75
Avg rating:3.0/5.0
Slides: 33
Provided by: imc78
Category:
Tags: hay | mermaids | noon | threw | truck

less

Transcript and Presenter's Notes

Title: They threw me off the hay truck at noon


1
They threw me off the hay truck at noon
2
Tumor-to-Tumor
  • Steven Sorscher

3
Case
  • 37 y/o female
  • 1975 (age 5) retinal hemangioma and
    blindness
  • 1987 balance difficulties, endolymphatic
    tumor
  • 1994,1996 hemangioblastomas resected
  • 1999 pancreatic neuroendocrine (NE) tumor,
    whipple, Dx with von Hippel-Lindau
  • 2002 Liver recurrence, NE tumor
  • 2006, 2008 Surgery for hemangioblastomas
    seeded with neuroendocrine tumor

4
Tumor-to-tumor
  • Von Hippel-Lindau An eponymic disease
  • Overview of metastases
  • Tumor-to-tumor metastases
  • CNS tumor-to-tumor
  • Novel treatment considerations

5
Von Hippel-Lindau (VHL)
  • Germline mutation or deletion in VHL gene
    (3p25-26)
  • 20 founder mutation
  • Tumor suppressor gene mechanism (Knudson 2-hit)
  • Hypoxia-inducing factor (HIF-1) expression and
    angiogenesis (VEGF) in response to hypoxia
  • Mutated VHL gene product does not degrade HIF-1,
    therefore
  • Chronic HIF activation causes increased VEGF and
    vascular proliferation
  • Death is usually due to RCCA, brain lesions or
    pheochromocytoma complications

6
Arch Nemeses
  • Superman
    VHL gene product
  • Humbert
    Lex Luther
  • Federer
    NY Yankees
  • Professor Moriarity
    Nadal
  • HIF
    Sherlock Holmes
  • Boston Red Socks
    Clare Quilty

7
(No Transcript)
8
  • I grow old ... I grow old ...
  • I shall wear the bottoms of my trousers rolled.
  •  
  • Shall I part my hair behind? Do I dare to eat a
    peach?
  • I shall wear white flannel trousers, and walk
    upon the beach.
  • I have heard the mermaids singing, each to each.
  • TS
    Elliott
  • To Create a monument that would have lasting
    significance..a landmark for our time

  • Eero Saarinen

9
VHL complications
  • Visceral
  • Renal Cell Carcinoma (RCC)
  • Renal cysts
  • Pheochromocytoma (missense mutation in 40 of
    families)
  • Pancreatic neuroendocrine tumors
  • Cystadenomas of the epididymis or broad ligament
  • CNS
  • Hemangioblastoma
  • Cerebellar tumors
  • Brain stem, spinal cord, retina
  • Endolymphatic sac tumors

10
Von-Hippel Lindau
  • 1904 Eugen von Hippel, angiomas of the eye
  • 1927 Arvid Lindau, angiomas of the cerebellum,
    spine
  • Eugen von Hippel (August 3, 1867 - September 5,
    1939) was a German ophthalmologist who was born
    in Königsberg. He studied medicine in Heidelberg
    under ophthalmologist Theodore Leber (1840-1917)
    and neurologist Wilhelm Heinrich Erb (1840-1921).
    In 1897 he attained the title of "professor
    extraordinary" at Heidelberg, and in 1909 became
    a professor at the eye clinic in Halle. In 1914
    he became a professor of ophthalmology in
    Göttingen.
  • In 1904, Hippel described a rare disorder of the
    retina, and in 1911 discovered the anatomical
    basis of this disease, which he named
    "angiomatosis retinae". However it wasn't until
    1926 that Swedish pathologist Arvid Lindau
    recognized an association between angiomatosis of
    the retina with hemangioblastomas of the
    cerebellum and other parts of the central nervous
    system. This condition is known today as the Von
    Hippel-Lindau Disease (VHL).
  • Hippel contributed several writings to textbooks
    regarding anatomy and diseases of the eye. He was
    the son of Arthur von Hippel (1841-1916), a
    pioneer in corneal transplantation, and an uncle
    to German-American physicist Arthur R. von Hippel
    (1898-2003).
  • Type 1 VHL angiomatosis w/o pheochromocytomas
  • Type 2 angiomatosis with pheochromocytomas
  • 2A Low RCCA risk
  • 2B high RCCA risk
  • 2C Pheochromocytomas only no
    angiomatosis or RCCA risk

11
Eugen von Hippel
  • "To those who met von Hippel briefly, he appeared
    reserved and withdrawn but whoever came to him
    with a real human need, be it as a patient
    seeking advice from him, as a pupil returning to
    him, or as a co-worker seeking with him the same
    goal in a clinical and scientific task, that
    person would find in Dr. von Hippel a rich
    helpful attitude and an unlimited and unshakeable
    confidence."
  • Dr. Baurmann, Karlsruhe Klinische
    Monatsblätter für Augenheilkunde, 1993, 103
    632-634.

12
Hatfield vs McCoy Feud
  • The Hatfields and McCoys have a storied and
    deadly history dating to Civil War times in the
    1860s. Their generations of fighting over land,
    timber rights and even a pig are the subject of
    dozens of books, songs and countless jokes.
    Unfortunately for rural Appalachia, the mountain
    area stretching from southern New York state to
    northern Mississippi, the feud is one of its
    greatest sources of fame. The spat officially
    ended with the formal truce declaration along the
    Kentucky-West Virginia border in 2003.
  • McCoys reportedly harbor a VHL mutation with
    high propensity to pheochromcytomas causing
    excess epinephrine, exposive tempers
  • Feud reportedly related to rage disease
    (Vanderbilt University, associated press)

13
Metastasis Overview
  • Clonal Expansion vs Rare Variant
    model
  • Clonal Expansion A rare variant becomes the
    dominant primary/majority cancer cell by out
    competing the others (Darwinian selection)
  • c/w common mutations in the primary and
    metastasis
  • Rare Variant A rare cell has no selective
    growth advantage, but is a highly metastatic
    variant and will not become the majority in the
    primary (punctuated equilibrium)
  • c/w Fidlers isolation of rare variants by
    subcloning in vitro or in vivo

14
Clonal Dominance Theory of Cancer Progression
  • A synthesis of clonal expansion and rare variant
    proposals
  • Kerbel tumor cells clones and tagged either with
    random or single site and innoculated into
    animals
  • Restriction length polymorphism analysis (RLPA)
    used to monitor primary and metastases
  • 1 innoculation of a single clone will dominate
    the primary (clonal expansion) and metastasize
    (rare variant)

15
Seed and Soil Donor factors
  • Subclone acquires specific characteristics
    (metastatic cascade)
  • Collagenases,proteases
  • Adhesion molecules (eg E-cadherin loss) or
  • CD44 involved in adhesion to hyaluronan (HA)
    expression is related to prognosis, metastatic
    potential
  • Angiogenesis (eg VEGF expression)
  • Integrins mediate cell, extracellular matrix
    interaction (eg loss of PTEN results in integrin
    alterations)
  • ECM exerts an influence on both normal and
    neoplastic cells which affects the
    assembly/disassembly of the matrix (eg dynamic
    reciprocity)

16
For example, the seed
  • Hypoxia induces
  • Reduced e-cadherin (loss of adhesion)
  • Plasminogen activating receptor expression
    (invasion)
  • Hepatocyte growth factor (HGF-MET) and cell
    migration to blood/lymphatics
  • Increased VEGF for angiogenesis and dissemination
    (and establishment of metastatic foci)
  • For VHL
  • Like Hypoxia, VHL mutation in RCC causes
    increased HIF, decreased e-cadherin, both
    re-established with WT VHL or dominant negative
    HIF. (Sullivan, Cancer Met
    Rev,2007)

17
Recipient Factors
  • Anatomical considerations
  • Vascularity
  • Potential for immune reaction
  • Changing micro-enviromental factors
  • eg curative resections and prolonged TT recur

18
For example, the soil
  • Bone marrow and a pre-metastatic niche
  • Clusters of hematopoietic progenitors cells
    express VEGFR-1 ( flt-1 ) and home to primary
    tumors to help growth.
  • These same cells are found at tumour specific
    premetastatic sites before tumor cells arrive
  • These cells express VLA-4 (an integrin) which
    allows a permissive environment for tumor
    colonization
  • This is prevented by antibodies to those cells or
    removal of those cells from WT mice either
    intervention prevents metastases

  • (Kaplan, Nature, 2005)

19
Tumor-to-tumor terminology
  • Tumor-to-tumor
  • Collision tumors
  • Piebald tumor

20
Case Reports
  • The changing face of case reports (eg explosion
    of information, intervention affecting biology,
    nuances of different hosts and tumors)
  • -Acinar cancer in HNPCC responding to Gemzar
  • -Hepatocellular cancer after RT for Hodgkins
    Lymphoma
  • True anomalies versus the extremes of a continuum
  • -Jill Price, hyperthymestic
  • The individual case should teach us something
    about the whole
  • To see the world in a grain of sand

21
  • To see a World in a Grain of SandAnd a Heaven in
    a Wild Flower,Hold Infinity in the palm of your
    hand And Eternity in an hour.
  •                                          -William
    Blake

22
Tumor-to-tumor Definition
  • More than one primary
  • Recipient is true benign or malignant tumor
  • Metatastic tumor is true metastasis (not
    collision, piebald, or emboli)
  • Excludes lymphoreticular

  • (Pamphlett,1984)

23
Tumor-to-tumor Considerations
  • Slow growing
  • Often not resected (eg hemangioblastoma)
  • Highly vascular
  • -mets tend to distribute to vascular areas (rim
    of ischemia in infarct, cerebral)

  • (Duffy, J Urol, 2004)

24
Tumor-to-tumor history
  • 1829 1st case reported
  • 1930 1st CNS case, lung to meningioma
  • 1968 22/34 cases, RCC was recipient
  • Most common donor lung cancer
  • Most common recipient renal cell carcinoma

25
Tumor-to-Tumor Sites
  • 150 cases reviewed
  • Donor
    Recipient
  • Lung (40-50)
    RCC (40-70)
  • Breast
    Sarcoma
  • Prostate
    Meningioma
  • Thyroid
    Thyroid

  • Pituitary adenoma

  • (Constantina, Int. J Path, 2004)

26
Tumor-to-CNS Tumor
  • Most common recipient meningioma (83)
  • Most common donor Lung and Breast (79)
  • 23/25 (92) had metastases to other sites

  • (Caroli,Neurosurg Rev, 2005)

27
Metastases to hemangioblastoma in VHL
  • 75 cases of resected hemangioblastoma in patients
    with VHL (2002-2005)
  • 5 cases with metastatic RCC to hemangioblastoma
  • 1 case neuroendocrine tumor metastatic to
    hemangioblastoma

  • (Jarrell,
    2006)

28
Renal cell and anti-angiogenesis
  • 116 patients, placebo vs low vs high dose
    bevacizumab
  • 4 months
    8 months
  • PFS(10mg/kg) 64
    30
  • Placebo Ab 20
    5
  • (Plt0.001)
  • Sutent/Sorafenib delay TTP 3-6 months

  • (NEJM,7-03,1-07)

29
Hemangioblastomas and anti-angiogenesis
  • Antiangiogenic agents in hemangioblastoma
  • Case Report
  • Symptomatic, unresectable hemangioblastoma C3/4
    in VHL patient
  • HIF family proteins are expressed (by IHC) in
    hemangioblastoma causing uncontrlloed vascular
    proliferation. High levels of VEGF were also
    detected
  • SU5416, VEGF TKI inhibitor led to resolution of
    hypaesthesia.. Spinal lesion was stable after 24
    months (clinical remission also seen in a patient
    with hemangioblastoma involving the optic nerve
    and for a patient with a retinal
    hemangioblastoma) (Schuch, JCO 2005)

30
Neuroendocrine tumors and anti-angiogenesis
  • Antiangiogenic agents in neuroendocrine tumors
  • 48 patients on stable octreotide doses
    randomized
  • Bevacizumab
    PEG IFN
  • PR 18
  • SD 77
    68
  • PD 5
    27
  • By CT blood flow was unchanged for IFN, but
    49 decrease at D2 for Bev (plt.01)

  • (Yao, JCO,2008)

31
Conclusions
  • More tumor-to-tumor might be expected with
    improved therapies but patterns will remain
    consistent
  • VHL tumorigenesis and progression is likely
    mediated by angiogenesis and refined
    antiangiogenic agents will be helpful
  • The metastatic phenotype is likely based on
    differing patterns of gene expression and
    individualized therapies may help

32
  • If you can dream--and not make dreams your
    master,
  • If you can think--and not make thoughts your
    aim
  • If you can meet with Triumph and Disaster
  • And treat those two impostors just the same


  • -R Kipling
Write a Comment
User Comments (0)
About PowerShow.com